BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37798461)

  • 1. Phenotypic and molecular characterization of novel pulmonary adenocarcinoma cell lines established from a dog.
    Kobayashi K; Takemura RD; Miyamae J; Mitsui I; Murakami K; Kutara K; Saeki K; Kanda T; Okamura Y; Sugiyama A
    Sci Rep; 2023 Oct; 13(1):16823. PubMed ID: 37798461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Recurrent Activating
    Lorch G; Sivaprakasam K; Zismann V; Perdigones N; Contente-Cuomo T; Nazareno A; Facista S; Wong S; Drenner K; Liang WS; Amann JM; Sinicropi-Yao SL; Koenig MJ; La Perle K; Whitsett TG; Murtaza M; Trent JM; Carbone DP; Hendricks WPD
    Clin Cancer Res; 2019 Oct; 25(19):5866-5877. PubMed ID: 31431454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma.
    Chiou GY; Cherng JY; Hsu HS; Wang ML; Tsai CM; Lu KH; Chien Y; Hung SC; Chen YW; Wong CI; Tseng LM; Huang PI; Yu CC; Hsu WH; Chiou SH
    J Control Release; 2012 Apr; 159(2):240-50. PubMed ID: 22285547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis.
    Packeiser EM; Hewicker-Trautwein M; Thiemeyer H; Mohr A; Junginger J; Schille JT; Murua Escobar H; Nolte I
    PLoS One; 2020; 15(3):e0230272. PubMed ID: 32168360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
    Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
    Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
    Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
    Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PD-L1, cancer stem cell and epithelial-mesenchymal transition phenotype in non-small cell lung cancer.
    Koh YW; Han JH; Haam S
    Pathology; 2021 Feb; 53(2):239-246. PubMed ID: 33036771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS Activation in Gastric Adenocarcinoma Stimulates Epithelial-to-Mesenchymal Transition to Cancer Stem-Like Cells and Promotes Metastasis.
    Yoon C; Till J; Cho SJ; Chang KK; Lin JX; Huang CM; Ryeom S; Yoon SS
    Mol Cancer Res; 2019 Sep; 17(9):1945-1957. PubMed ID: 31217166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential.
    Salnikov AV; Liu L; Platen M; Gladkich J; Salnikova O; Ryschich E; Mattern J; Moldenhauer G; Werner J; Schemmer P; Büchler MW; Herr I
    PLoS One; 2012; 7(9):e46391. PubMed ID: 23050024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRT6A Promotes EMT and Cancer Stem Cell Transformation in Lung Adenocarcinoma.
    Yang B; Zhang W; Zhang M; Wang X; Peng S; Zhang R
    Technol Cancer Res Treat; 2020; 19():1533033820921248. PubMed ID: 32329414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells.
    Xu MH; Gao X; Luo D; Zhou XD; Xiong W; Liu GX
    PLoS One; 2014; 9(2):e87893. PubMed ID: 24516569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-Resistant TNBC Cells Exhibit Rapid Growth with Cancer Stem Cell-like Properties and EMT Phenotype, Which Can Be Transferred to Parental Cells through Autocrine Signaling.
    Paramanantham A; Jung EJ; Kim HJ; Jeong BK; Jung JM; Kim GS; Chan HS; Lee WS
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes.
    Gomez-Casal R; Bhattacharya C; Ganesh N; Bailey L; Basse P; Gibson M; Epperly M; Levina V
    Mol Cancer; 2013 Aug; 12(1):94. PubMed ID: 23947765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of CD133 positive cells in four novel HPV-16 positive cervical cancer-derived cell lines and biopsies of invasive cervical cancer.
    Javed S; Sharma BK; Sood S; Sharma S; Bagga R; Bhattacharyya S; Rayat CS; Dhaliwal L; Srinivasan R
    BMC Cancer; 2018 Apr; 18(1):357. PubMed ID: 29609538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation.
    Kurimoto R; Iwasawa S; Ebata T; Ishiwata T; Sekine I; Tada Y; Tatsumi K; Koide S; Iwama A; Takiguchi Y
    Int J Oncol; 2016 May; 48(5):1825-36. PubMed ID: 26984042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.
    Gonçalves Ndo N; Colombo J; Lopes JR; Gelaleti GB; Moschetta MG; Sonehara NM; Hellmén E; Zanon Cde F; Oliani SM; Zuccari DA
    PLoS One; 2016; 11(3):e0150407. PubMed ID: 26934679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties.
    Si J; Ma Y; Bi JW; Xiong Y; Lv C; Li S; Wu N; Yang Y
    J Exp Clin Cancer Res; 2019 Dec; 38(1):481. PubMed ID: 31801598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.
    Navas T; Pfister TD; Colantonio S; Aziz A; Dieckman L; Saul RG; Kaczmarczyk J; Borgel S; Alcoser SY; Hollingshead MG; Lee YH; Bottaro DP; Hiltke T; Whiteley G; Takebe N; Kinders RJ; Parchment RE; Tomaszewski JE; Doroshow JH
    PLoS One; 2018; 13(6):e0199361. PubMed ID: 29928062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed death ligand 1 regulates epithelial-mesenchymal transition and cancer stem cell phenotypes in hepatocellular carcinoma through the serum and glucocorticoid kinase 2/β-catenin signaling pathway.
    Kong X; Peng H; Liu P; Fu X; Wang N; Zhang D
    Cancer Sci; 2023 Jun; 114(6):2265-2276. PubMed ID: 36751987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.